immune system
|
|
• accelerated apoptosis in freshly isolated thymocytes after tunicamycin treatment
|
small thymus
(
J:274469
)
|
|
• decreased thymus size in young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
|
|
|
• decreased thymus weight in young adult and older mice
|
|
|
• reduced total thymocyte number in young adult and older mice
• however, development of double-negative (DN) thymocytes and CD4+ and CD8+ single-positive (SP) thymocytes is normal
• no significant change in DN1-4 thymic subsets
|
|
|
• decreased % of naive (CD44lowCD62Lhi) in CD4+ and CD8+ T cells in the spleen and lymph nodes of young adult (8-wk-old) and older mice (6-mo-old)
|
|
|
• increased % of effector/memory T cells (CD44hiCD62Llo) in CD4+ and CD8+ T cells in the spleen and lymph nodes of young adult (8-wk-old) and older mice (6-mo-old)
|
|
|
• decreased percentage of CD4+ and CD8+ single positive (SP) mature T lymphocytes in the spleen and lymph nodes of young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
• decreased percentage of CD4+ and CD8+ T cells in peripheral blood
• however, expression of class I MHC molecules on CD4+ and CD8+ SP splenocytes is normal
|
|
|
• marked reduction in IL-2 and IFN-gamma production following stimulation of total splenocytes with anti-CD3 plus anti-CD28
|
|
|
• reduced T cell proliferation following stimulation of total splenocytes with anti-CD3 plus anti-CD28
|
|
|
• marked reduction in IFN-gamma production following stimulation of total splenocytes with anti-CD3 plus anti-CD28; also detected at the mRNA level
|
|
• marked reduction in IL-2 production following stimulation of total splenocytes with anti-CD3 plus anti-CD28; also detected at the mRNA level
|
hematopoietic system
|
|
• accelerated apoptosis in freshly isolated thymocytes after tunicamycin treatment
|
small thymus
(
J:274469
)
|
|
• decreased thymus size in young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
|
|
|
• decreased thymus weight in young adult and older mice
|
|
|
• reduced total thymocyte number in young adult and older mice
• however, development of double-negative (DN) thymocytes and CD4+ and CD8+ single-positive (SP) thymocytes is normal
• no significant change in DN1-4 thymic subsets
|
|
|
• decreased % of naive (CD44lowCD62Lhi) in CD4+ and CD8+ T cells in the spleen and lymph nodes of young adult (8-wk-old) and older mice (6-mo-old)
|
|
|
• increased % of effector/memory T cells (CD44hiCD62Llo) in CD4+ and CD8+ T cells in the spleen and lymph nodes of young adult (8-wk-old) and older mice (6-mo-old)
|
|
|
• decreased percentage of CD4+ and CD8+ single positive (SP) mature T lymphocytes in the spleen and lymph nodes of young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
• decreased percentage of CD4+ and CD8+ T cells in peripheral blood
• however, expression of class I MHC molecules on CD4+ and CD8+ SP splenocytes is normal
|
|
|
• marked reduction in IL-2 and IFN-gamma production following stimulation of total splenocytes with anti-CD3 plus anti-CD28
|
|
|
• reduced T cell proliferation following stimulation of total splenocytes with anti-CD3 plus anti-CD28
|
cellular
|
|
• accelerated apoptosis in freshly isolated thymocytes after tunicamycin treatment
|
|
|
• reduced T cell proliferation following stimulation of total splenocytes with anti-CD3 plus anti-CD28
|
endocrine/exocrine glands
|
|
• accelerated apoptosis in freshly isolated thymocytes after tunicamycin treatment
|
small thymus
(
J:274469
)
|
|
• decreased thymus size in young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
|
|
|
• decreased thymus weight in young adult and older mice
|
|
|
• reduced total thymocyte number in young adult and older mice
• however, development of double-negative (DN) thymocytes and CD4+ and CD8+ single-positive (SP) thymocytes is normal
• no significant change in DN1-4 thymic subsets
|


Analysis Tools